Soligenix Encourages Stockholders to Vote their Shares at the Annual Meeting
Most shareholders can vote by calling 1-833-782-7145
Only one day left to vote
PRINCETON, N.J., May 29, 2024 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, encourages its eligible stockholders to vote their shares at the upcoming reconvened meeting on May 30, 2024. The Company and its Board of Directors believe it is important for all stockholders to make their voices heard. The Company urges all stockholders to exercise their right to vote their shares by proxy TODAY.